Advertisement

etomidate Injection

[27 September 2016]

Products Affected - Description

Amidate injection, Hospira
2 mg/mL, 10 mL ampule, 5 count (NDC 00409-8062-01)
2 mg/mL, 20 mL LifeShield syringe, 10 count (NDC 00409-8060-29)
2 mg/mL, 20 mL ampule, 5 count (NDC 00409-8061-01)
 
Etomidate injection, Mylan Institutional
2 mg/mL, 20 mL vial, 10 count (NDC 67457-0456-21)

Reason for the Shortage

  • American Regent had etomidate injection on shortage due to manufacturing delays.
  • Ben Venue stopped production in its plant in Bedford, Ohio and closed in July 2014.
  • Hospira has Amidate on shortage due to manufacturing delays.
  • Par Sterile Products discontinued etomidate in early 2015.
  • Sagent is no longer marketing etomidate.

Available Products

Amidate intravenous injection, Hospira
2 mg/mL, 10 mL vial, 10 count (NDC 00409-6695-01)
2 mg/mL, 20 mL vial, 10 count (NDC 00409-6695-02)
 
Etomidate injection, American Regent
2 mg/mL, 10 mL vial, 10 count (NDC 00517-0780-10)
2 mg/mL, 20 mL vial, 10 count (NDC 00517-0781-10)
 
Etomidate injection, Mylan Institutional
2 mg/mL, 10 mL vial, 10 count (NDC 67457-0477-10)
2 mg/mL, 20 mL vial, 10 count (NDC 67457-0456-21)
 
Etomidate injection, Zydus
2 mg/mL, 10 mL vial, 10 count (NDC 68382-0545-07)
2 mg/mL, 20 mL vial, 10 count (NDC 68382-0545-08)

Estimated Resupply Dates

  • Hospira has etomidate 20 mL LifeShield syringes, 10 mL ampules, and 20 mL ampules on back order and the company cannot estimate a release date.
  • Mylan Institutional has etomidate 20 mL vials on back order and the company estimates a release date of early-December 2016.

Safety

Clinicians must take extra care to ensure safe use of etomidate when using different presentations than those normally stocked.

Related Shortages

Updated

September 27, August 25, June 2, January 29, 2016; December 11, November 30, October 29, September 4, August 24 and 13, July 15, April 28, 17 and 16, March 23 and 2, February 12, 2015; December 22 and 18, October 3, September 17 and 5, August 7 and 1, July 15 and 8, May 16, March 31 and 20, February 27 and 21, January 24, 2014; December 12 and 6, October 24 and 9, September 3, July 25, June 29 and 11, May 28 and 7, April 23, 9 and 3, March 8, February 25 and 13, January 31, 29, 22 and 11, 2013; December 14 and 7, November 19 and 5, October 4, September 14, August 7, July 25 and 19, June 18, May 29 and 2, April 3, March 21, 14 and 2, February 27, 14 and 7, January 31, 27 and 4, 2012; December 19 and 6, October 26, August 31 and 3, July 6, 2011, University of Utah, Drug Information Service. Copyright 2016, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement
ASHP Product Listing